Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ronald M Bukowski

Showing results (1-10 of 145) with videos related to

Pageof 15
Sort By:
Expert Opinion on Investigational Drugs|July 29, 2003
AE-941, a multifunctional antiangiogenic compound: trials in renal cell carcinomaRonald M Bukowski
Oncology (Williston Park, N.Y.)|June 16, 2006
Targeted therapy for cytokine-refractory metastatic renal cell carcinoma, and treatment in the communityRonald M Bukowski
Current Oncology Reports|December 6, 2001
Development of novel signal transduction inhibitors; recent phase I trialsRonald M Bukowski
Current Oncology Reports|January 29, 2011
Biomarkers in renal cell carcinoma: what next?Ronald M Bukowski
Cancer|April 30, 2009
Prognostic factors for survival in metastatic renal cell carcinoma: update 2008Ronald M Bukowski
Clinical Genitourinary Cancer|February 14, 2009
Tyrosine kinase inhibitors in advanced renal cell carcinoma: the evolving treatment paradigmRonald M Bukowski
Current Oncology Reports|February 17, 2009
Axitinib treatment in patients with cytokine-refractory metastatic renal cell cancerRonald M Bukowski
Expert Opinion on Pharmacotherapy|July 1, 2010
Systemic therapy for metastatic renal cell carcinoma in treatment naïve patients: a risk-based approachRonald M Bukowski
Current Oncology Reports|April 2, 2008
Randomized trial of bevacizumab in advanced renal cell carcinomaRonald M Bukowski
Cancer Management and Research|September 21, 2011
Critical appraisal of pazopanib as treatment for patients with advanced metastatic renal cell carcinomaRonald M Bukowski
Pageof 15

Showing results (1-10 of 145) with videos related to

Sort By:
Pageof 15
Expert Opinion on Investigational Drugs|July 29, 2003
AE-941, a multifunctional antiangiogenic compound: trials in renal cell carcinomaRonald M Bukowski
Oncology (Williston Park, N.Y.)|June 16, 2006
Targeted therapy for cytokine-refractory metastatic renal cell carcinoma, and treatment in the communityRonald M Bukowski
Current Oncology Reports|December 6, 2001
Development of novel signal transduction inhibitors; recent phase I trialsRonald M Bukowski
Current Oncology Reports|January 29, 2011
Biomarkers in renal cell carcinoma: what next?Ronald M Bukowski
Cancer|April 30, 2009
Prognostic factors for survival in metastatic renal cell carcinoma: update 2008Ronald M Bukowski
Clinical Genitourinary Cancer|February 14, 2009
Tyrosine kinase inhibitors in advanced renal cell carcinoma: the evolving treatment paradigmRonald M Bukowski
Current Oncology Reports|February 17, 2009
Axitinib treatment in patients with cytokine-refractory metastatic renal cell cancerRonald M Bukowski
Expert Opinion on Pharmacotherapy|July 1, 2010
Systemic therapy for metastatic renal cell carcinoma in treatment naïve patients: a risk-based approachRonald M Bukowski
Current Oncology Reports|April 2, 2008
Randomized trial of bevacizumab in advanced renal cell carcinomaRonald M Bukowski
Cancer Management and Research|September 21, 2011
Critical appraisal of pazopanib as treatment for patients with advanced metastatic renal cell carcinomaRonald M Bukowski
Pageof 15